AI biotech Insilico Medicine goes for third attempt at Hong Kong IPOnews2025-05-09T09:15:26+00:00May 9th, 2025|Endpoints News|
HAYA Therapeutics gets $65M for ‘dark genome’ work following last year’s Lilly pactnews2025-05-08T12:00:37+00:00May 8th, 2025|Endpoints News|
Degradation startup raises $39M for pivot to PROTACs and clinical entrynews2025-05-06T11:00:55+00:00May 6th, 2025|Endpoints News|
Singapore cardio gene therapy biotech collects $45M as it plots Europe expansionnews2025-05-06T05:00:34+00:00May 6th, 2025|Endpoints News|
Function buys Ezra, combining preventive testing and scansnews2025-05-05T16:00:54+00:00May 5th, 2025|Endpoints News|
Deerfield secures $600M+ for third healthcare venture fund to seed new companiesnews2025-05-05T11:00:53+00:00May 5th, 2025|Endpoints News|
Pathos AI gets AstraZeneca funding as biotech plans to raise up to $400Mnews2025-05-02T14:55:42+00:00May 2nd, 2025|Endpoints News|
How SalioGen’s attempt to turn ‘jumping genes’ into medicines fell apartnews2025-05-02T11:00:28+00:00May 2nd, 2025|Endpoints News|
Artios cancer drug shrinks subset of tumors in early studynews2025-04-29T19:46:12+00:00April 29th, 2025|Endpoints News|
With a new CEO, oligonucleotide biotech Creyon forges Eli Lilly partnershipnews2025-04-29T14:07:03+00:00April 29th, 2025|Endpoints News|
